GlassScriptPhysician profile
William R Sims
NPI 1790779494
$1,381.94
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,382.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $355.95 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $193.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.47 | 2019 | |
| Grifols USA, LLC | $135.20 | 2019 | |
| Inspire Medical Systems, INC. | $108.94 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $86.66 | 2019 | |
| Novartis Pharmaceuticals Corporation | $64.66 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $53.00 | 2019 | |
| Pfizer INC. | $42.00 | 2019 | |
| Insmed, INC. | $35.37 | 2019 | |
| Genentech USA, INC. | $33.14 | 2019 | |
| Resmed Corp | $30.80 | 2019 | |
| Shire North American Group INC | $24.11 | 2019 | |
| Electromed, INC. | $16.77 | 2019 | |
| Merck Sharp & Dohme LLC | $16.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15.11 | 2019 | |
| Gilead Sciences, INC. | $12.21 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.